• SENSEX 80,567.71
    409.83 (+0.51%)
  • BANKNIFTY 54,067.55
    406.55 (+0.76%)
  • Ola Electric
    70.25 123.90(%)
  • N S D L
    1,236.20 880.00(%)
  • Aditya Vision
    447.00 328.25(%)
  • Vimta Labs
    829.00 787.20(%)
  • One Mobikwik
    300.00 698.30(%)
  • Tata Steel
    168.00 170.20(%)
  • Netweb Technol.
    2,564.75 3,060.00(%)
  • Apollo Micro Sys
    306.60 298.70(%)
  • Aurobindo Pharma
    1,041.00 1,592.55(%)
  • Jai Corp
    170.15 406.00(%)
  • Moschip Tech.
    196.45 279.00(%)
  • Godfrey Phillips
    10,420.00 11,462.00(%)
  • Yes Bank
    20.38 24.40(%)
  • M & M
    3,292.60 3,430.10(%)
  • NTPC
    333.45 292.70(%)
  • TBO Tek
    1,609.20 2,000.00(%)
  • AU Small Finance
    716.05 840.95(%)
  • Larsen & Toubro
    3,606.35 3,963.00(%)
  • TCS
    3,087.75 2,992.05(%)
  • Bharat Electron
    381.05 435.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Shilpa Medicare Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5031.0
  • ISIN : INE790G01031
844.45 6 (0.69%)
  • As on 03 Sep 2025 (EOD)
  • Today’s Low

    840.00
  • Today’s High

    853.00
  • Open

    841.00
  • Perv Close

    838.65
  • 52W Low

    555.00
  • 52W High

    1,000.00

Key Indicators

  • P/E(TTM)

    75.75

  • Mar.Cap (₹Cr.)

    8,201.23

  • Div & Yield %

    0.12

  • Book Value(₹)

    276.16

  • Debt-Equity Ratio

    0.69

  • AGM Date

    03-Sep-2025

  • EPS

    11.08

  • P/E Ratio

    75.75

Financials Ratios

  • Debt-Equity Ratio

    0.48

  • Mar.Cap (₹Cr.)

    8,201.23

  • RONW (%)

    1.72

  • ROCE (%)

    5.16

Score Board

  • Equity (₹ in Cr.)

    9.78

  • BV (₹)

    276.20

  • Sales( ₹ in Cr.)

    477.34

  • NP (in Cr.)

    94.83

  • NP Var(%)

    180.0

  • Div%

    100.0

  • CPS (₹)

    14.70

  • EPS (₹)

    9.70

  • Traded Value (₹ in Lakhs)

    8,208.08

  • 52 Week High

    1,000.00

  • 52 Week Low

    555.00

  • Price BSE

    839.0

  • Price NSE

    839.00

  • Market Capital( in Cr.)

    8,208.08

  • P/C Ratio

    57.10

  • P/E Ratio

    86.50

  • Price Vs.BV

    9.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 477.34 309.79 247.70 356.95 257.05 805.97
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 477.34 309.79 247.70 356.95 257.05 805.97
Other Income 84.85 89.12 175.32 170.50 204.49 36.79
Stock Adjustments -6.00 -2.63 -4.08 3.18 10.26 14.26
Total Income 556.19 396.28 418.94 530.63 471.80 857.02
EXPENDITURE :            
Raw Materials 114.50 86.62 78.12 81.96 69.37 279.83
Power and Fuel Cost 17.96 18.73 18.70 17.47 12.42 35.31
Employee Cost 99.61 103.64 109.54 110.57 76.10 149.28
Other Manufacturing Expenses 13.24 15.32 18.28 22.79 16.71 35.94
Selling and Administration Expenses 101.45 49.74 60.03 106.22 55.92 67.02
Miscellaneous Expenses 46.72 17.26 18.50 -0.57 3.43 12.50
Employee Benefit Expenses 99.61 103.64 109.54 110.57 76.10 149.28
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 393.49 291.31 303.17 338.44 233.95 579.87
Operating Profit 162.69 104.96 115.78 192.18 237.86 277.15
Interest 6.60 17.26 20.83 9.05 6.07 4.33
Gross Profit 156.09 87.70 94.95 183.13 231.79 272.82
Depreciation 48.86 49.61 46.55 34.82 22.28 34.96
Profit Before Tax 107.23 38.09 48.40 148.31 209.51 237.86
Current Tax 47.08 11.29 -8.37 4.80 15.78 39.09
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -9.64 -0.13 -0.43 2.53 9.34 5.05
Reported Net Profit 69.80 26.94 57.19 140.99 184.39 193.72
Extraordinary Items -25.03 -6.93 -15.86 8.23 46.40 -3.65
Adjusted Net Profit 94.83 33.87 73.05 132.76 137.99 197.37
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 1,359.05 1,332.11 1,284.46 1,152.44 968.05 794.97
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 9.55 8.97 0.00 20.64
P & L Balance carried down 1,428.85 1,359.05 1,332.11 1,284.46 1,152.44 968.05
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 100.00 0.00 0.00 110.00 110.00 110.00
Dividend Per Share(Rs) 1.00 0.00 0.00 1.10 1.10 1.10
Earnings Per Share-Unit Curr 7.14 3.10 6.59 16.24 22.62 23.76
Earnings Per Share(Adj)-Unit Curr 7.14 3.10 6.59 16.24 22.62 23.76
Book Value 276.16 246.85 243.96 237.97 200.89 178.27
Book Value(Adj)-Unit Curr 276.16 246.85 243.96 237.97 200.89 178.27

Shareholding Pattern

  • Promoter Group

    44.23%

  • Public Share Holding

    55.77%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 43,249,715 44.23 43,249,715 23
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 43,249,715 44.23 43,249,715 23
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 502 0.00 502 2
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 1,500 0.00 1,500 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 10,946,921 11.19 10,946,921 97
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,926,798 1.97 1,926,798 2
Mutual Funds / UTI 3,963,485 4.05 3,963,485 9
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,407,508 1.44 1,407,508 9
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 18,246,714 18.66 18,246,714 120
2] Non Institution
Bodies Corporate 10,046,438 10.27 10,046,438 745
Clearing Members 7,565 0.01 7,565 5
Directors of their Relatives 31,075 0.03 31,075 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,468,741 2.52 2,468,741 1,099
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 755,239 0.77 755,239 1,178
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,654,783 6.81 6,654,783 12
Individuals holding nominal share capital up to Rs. 1 lakh 16,042,258 16.40 15,917,494 45,446
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,033 0.00 2,033 4
Others 286,347 0.29 286,347 2
Sub Total 36,294,479 37.11 36,169,715 48,493
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 97,790,908 100.00 97,666,144 48,636

Company Background

Shilpa Medicare LtdPharmaceuticals - Indian - Formulations

  • Shilpa Medicare Ltd
  • BSE Code : 5031.0
  • ISIN : INE790G01031
  • Incorporation Year

    1987

  • Registered Office

    #12-6-214/A1
    Hyderabad Road, Raichur,
    Karnataka-584135

  • Telephone

    91-8532-238704

  • FAX

    91-8532238876

  • Chairman

    Omprakash Inani

  • Managing Director

    Vishnukant Bhutada

  • Company Secretary

    Ritu Tiwary

  • Auditor

    Bohara Bhandari Bung And Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Shilpa Medicare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Shilpa Medicare 839.35 561.18 477.34 133.02 6.20
Abbott India 32,356.30 6,684.73 6,409.15 47.34 44.95
Astrazeneca Phar 8,937.85 1,756.92 1,716.29 121.87 32.94
P & G Health Ltd 6,321.25 944.52 934.17 34.91 40.23
Glaxosmi. Pharma 2,749.15 3,866.05 3,723.49 49.44 58.72
Cipla 1,568.95 20,029.57 19,044.85 23.45 21.40
Amrutanjan Healt 729.20 469.50 451.82 38.66 21.89
Guj. Themis Bio. 376.95 152.47 150.80 92.16 27.21
Fermenta Biotec. 328.45 442.21 430.53 10.90 17.61
Bliss GVS Pharma 159.40 703.42 667.20 23.83 9.16
Ambalal Sarabhai 32.71 19.33 4.04 17.13 2.10